When.com Web Search

  1. Ads

    related to: fda approved prostate cancer medication list

Search results

  1. Results From The WOW.Com Content Network
  2. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  3. Cabazitaxel - Wikipedia

    en.wikipedia.org/wiki/Cabazitaxel

    It is a microtubule inhibitor, [2] and the fourth taxane to be approved as a cancer therapy. [citation needed] Cabazitaxel was developed by Sanofi-Aventis and was approved by the US Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer in June 2010. [5] [6] [7] It is available as a generic medication. [8] [9]

  4. Degarelix - Wikipedia

    en.wikipedia.org/wiki/Degarelix

    In December 2008, the US Food and Drug Administration (FDA) approved degarelix for the treatment of people with advanced prostate cancer. [ 13 ] [ 14 ] It was subsequently approved by the European Commission at the recommendation of the European Medicines Agency (EMA) in February 2009, for use in adult males with advanced, hormone-dependent ...

  5. Relugolix - Wikipedia

    en.wikipedia.org/wiki/Relugolix

    Relugolix was approved for the treatment of uterine fibroids in Japan in January 2019. [12] [13] It was the second orally active GnRH antagonist to be introduced for medical use, following elagolix (brand name Orilissa) in July 2018. [12] [17] Relugolix was approved for the treatment of prostate cancer in the United States on 18 December 2020 ...

  6. Leuprorelin - Wikipedia

    en.wikipedia.org/wiki/Leuprorelin

    Viadur was approved by the FDA for palliative treatment of advanced prostate cancer on 6 March 2000. [7] Eligard was approved by the FDA for palliative treatment of advanced prostate cancer on 24 January 2002. [5] Fensolvi was approved by the FDA for children with central precocious puberty on 4 May 2020. [6] [46]

  7. AstraZeneca-Merck Lynparza Prostate Cancer Treatment Gets FDA ...

    www.aol.com/news/astrazeneca-merck-lynparza...

    AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate ...

  1. Ads

    related to: fda approved prostate cancer medication list